Sort
39,280 grants matching “leukemia”
Methods for Bioactive Compound Synthesis
$367,871Paul R. Hanson · University Of Kansas Lawrence · R01 · FY2016 · GM
A Rapid and Comprehensive Approach for Clinical Genomic Profiling in Lung Cancer
$367,837Eric J Duncavage · Washington University · R33 · FY2024 · CA
Alpha-Particle Immunotherapy of Cancer
$367,799David A Scheinberg · Sloan-Kettering Inst Can Research · R01 · FY2006 · CA
Interplay of Myc, Tumor Supressors and Regulators of Differentiation in Lymphoma
$367,778John L. Cleveland · Scripps Florida · R01 · FY2010 · CA
Interplay of Myc, Tumor Supressors and Regulators of Differentiation in Lymphoma
$367,778John L. Cleveland · Scripps Florida · R01 · FY2009 · CA
Studies on peripheral B lymphocyte development
$367,766Shiv Subramaniam Pillai · Massachusetts General Hospital · R01 · FY2007 · AI
Molecular Mechanism of Leukemogenesis involving AML1-ETO
$367,745Dong-Er Zhang · University Of California, San Diego · R01 · FY2022 · CA
DNA Adducts of Styrene and Other Vinyl Monomers
$367,735Michael P Stone · Vanderbilt University · R01 · FY2010 · ES
Mechanisms of Hematopoietic Stem Cell Maintenance
$367,710Emmanuelle Passegue · University Of California, San Francisco · R01 · FY2013 · HL
Project 1: Increasing therapeutic efficacy in isocitrate dehydrongenase (IDH)âmutant acute myeloid leukemia (AML)
$367,707Ross L Levine · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Project 3: Therapeutic inhibition of splicing through inhibition of protein arginine methylation in leukemia
$367,707Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Project 2: Defining and exploiting genetic dependencies in complex karyotype AML
$367,707Scott W Lowe · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Project 4: Chimeric Antigen Receptor T Cell Therapy for the Treatment of Acute Myeloid Leukemia
$367,707Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Project 3 - Immune analysis of clinical trial samples
$367,678Gerald P Linette · University Of Pennsylvania · P01 · FY2022 · CA
Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment
$367,664Steven David Mittelman · University Of California Los Angeles · R01 · FY2018 · CA
ZFN-Modified Stem Cells for HIV Eradication
$367,655Philip D Gregory · Fred Hutchinson Cancer Research Center · U19 · FY2011 · AI
Discovery of New Targets and Pathways for T-ALL Therapy
$367,619A Thomas Look · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Electrochemical based DNA sensors
$367,607Jacqueline K Barton · California Institute Of Technology · R01 · FY2015 · GM
Electrochemical based DNA sensors
$367,607Jacqueline K Barton · California Institute Of Technology · R01 · FY2016 · GM
Electrochemical based DNA sensors
$367,607Jacqueline K Barton · California Institute Of Technology · R01 · FY2017 · GM
Electrochemical based DNA sensors
$367,607Jacqueline K Barton · California Institute Of Technology · R01 · FY2014 · GM
CANCER AND LEUKEMIA GROUP B--RPCI/SUNYAB
$367,544Roswell Park Cancer Institute Corp · U10 · FY2002 · CA
FLow Cytometric Detection of Malignant Cells in Body Fluids
$367,503Maryalice Stetler-Stevenson · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Flow Cytometric Evaluation of Biomarkers
$367,503Maryalice Stetler-Stevenson · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Follicular Exclusion of Self Antigens Prevents Development of Autoantibodies
$367,500John D Mountz · University Of Alabama At Birmingham · R01 · FY2018 · AI